Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-12.3M -10.34M -11.41M -13.24M -12.35M -10.9M -7.82M -7.7M -7.14M -6.4M -5.5M -8.27M -8.05M -7.33M -8.52M -7.25M -9.79M -8.37M
Depreciation & Amortization
38K 37K 38K 36K 38K 35K 35K 35K 34K 19K 15K 9K 8K 11K 12K 13K 12K 13K
Stock-Based Compensation
1.38M 1.21M 917K 821K 1.13M 723K 534K 530K 605K 578K 501K 569K 520K 737K 540K 540K 745K 718K
Other Working Capital
-503K -2.11M -790K 3.02M 3.35M -356K 109K 377K -2.38M 914K -1.42M 654K -910K 434K 1.02M 560K -2.03M 1.13M
Other Non-Cash Items
-273K -283K -99K 5.49M -223K -261K 134K 119K 239K -580K -460K -74K 207K 165K 157K 151K 521K 145K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 23K -472K -631K n/a n/a n/a n/a n/a -53K 5K -40K 6K
Change in Working Capital
1.05M -4.1M 1.01M -2.67M 2.73M -62K 736K 207K -2.98M -1.81M -882K -814K 1.14M -676K 1.64M -695K 658K -89K
Operating Cash Flow
-10.1M -13.48M -9.55M -9.56M -8.68M -10.47M -6.36M -7.28M -9.88M -8.2M -6.33M -8.58M -6.18M -7.09M -6.23M -7.24M -7.9M -7.58M
Capital Expenditures
n/a 13.48M -7K n/a -28K n/a -22K -18K -40K -57K -116K -43K n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a -671K 1.2M -1.96M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-17.11M -27.55M -45.19M -13.05M -9.96M -30.26M -951K n/a n/a -8.98M -65.19M -6.81M -54.22M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
14.12M 17.59M 21.33M 19.65M 12.75M 22.17M 13.82M 18M 19.68M 18M 17M 2M -72K n/a n/a n/a n/a n/a
Other Investing Acitivies
383K n/a n/a 1.07M n/a n/a n/a n/a 19.68K 671K -1.2M 1.96M 72K n/a n/a n/a n/a n/a
Investing Cash Flow
-2.61M -9.95M -23.87M 7.67M 2.77M -8.09M 12.85M 17.98M 19.64M 8.96M -48.31M -4.85M -54.22M n/a n/a n/a n/a n/a
Debt Repayment
n/a -11K -31K -32K -31K -32K -32K -31K -7.69M -1.75M -1.75M -1.75M -1.75M -583K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 49K 163K 4.85M n/a 1.71M n/a 28K 47K 2K 5.87M 5.9M -42K 63K -399K -41K -31K
Financial Cash Flow
110.39M 8.71M 51.47M 4.98M 5.07M -28K -54K 1.51M -7.66K -1.7K 652K 55.3M 55.98M -625K 13.74M 134K 2.75M 4.15M
Net Cash Flow
97.68M -14.72M 18.05M 3.09M -848K -18.59M 6.43M 12.21M 2.1M -938K -53.98M 41.88M -4.42M -7.72M 7.51M -7.11M -5.14M -3.43M
Free Cash Flow
-10.1M -13.48M -9.56M -9.56M -8.71M -10.47M -6.38M -7.3M -9.91M -8.25M -6.45M -8.62M -6.18M -7.09M -6.23M -7.24M -7.9M -7.58M